Clinical trials for Germ cell tumor
48 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07552233NK Cell Therapy for Malignant Solid Brain TumorsPeking University Third Hospital
- RECRUITINGNCT07314164Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior TreatmentIpsen · PI: Ipsen Medical Director
- RECRUITINGPhase 1NCT07143812A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed GlioblastomaCHA University · PI: Jaejoon Lim, PhD
- RECRUITINGN/ANCT06910306Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaAlpha Tau Medical LTD.
- RECRUITINGN/ANCT07459101UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-4Sunnybrook Health Sciences Centre
- RECRUITINGPHASE1, PHASE2NCT07193966NG2 and DLL3 CAR-T Cells Targeting MelanomaShenzhen Geno-Immune Medical Institute
- RECRUITINGPhase 2NCT06712927Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain MetastasesStanford University · PI: Allison B Warner, MD, PhD
- RECRUITINGPHASE1, PHASE2NCT06712875MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric GliomasAnn & Robert H Lurie Children's Hospital of Chicago · PI: Ashley Plant-Fox, MD
- RECRUITINGPHASE1, PHASE2NCT06440057Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.Suzhou Zelgen Biopharmaceuticals Co.,Ltd · PI: Jason Wu
- RECRUITINGPHASE2, PHASE3NCT06855095Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA TrialThe Netherlands Cancer Institute
- ACTIVE NOT RECRUITINGPhase 3NCT06640530Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the SkinBiocad
- ACTIVE NOT RECRUITINGNCT06598137Study to Examine Lesions of the Skin Using Confocal Laser MicroscopyLMU Klinikum
- ACTIVE NOT RECRUITINGN/ANCT06204159Lipiodol Deposition Using Endhole vs. Pressure-Modulated DeliveryAbramson Cancer Center at Penn Medicine
- RECRUITINGN/ANCT06454097Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in GliomasBeijing Tiantan Hospital · PI: Yinyan Wang, MD and PhD
- RECRUITINGNCT05867004Blocking TNF to Potentiate the ICI-dependent Immune Awakening in MelanomaInstitut Claudius Regaud · PI: Bruno SEGUI, Pr
- ACTIVE NOT RECRUITINGPhase 1NCT05249114Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine TumorsProvidence Health & Services · PI: Hagen Kennecke, MD
- RECRUITINGN/ANCT05911230Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain MetastasesUniversity Hospital, Basel, Switzerland · PI: Dominik Cordier, PD Dr. med.
- RECRUITINGPhase 2NCT05463848Surgical Pembro +/- Olaparib w TMZ for rGBML. Nicolas Gonzalez Castro, MD, PhD · PI: Luis N Gonzalez Castro, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05326464Tofacitinib in Recurrent GBM PatientsUniversity of Texas Southwestern Medical Center · PI: Michael Youssef, MD
- RECRUITINGN/ANCT05310448Tumor Treating Fields for the Treatment of Brainstem GliomasEmory University · PI: Jim Zhong, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05270044Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.Pierre Fabre Medicament · PI: Alexander C.J. van AKKOOI, MD, PhD
- RECRUITINGN/ANCT05253872The MELAcare Study: A New Method for Surveillance of Melanoma PatientsHerlev and Gentofte Hospital · PI: Lisbet R Hölmich, Professor
- ACTIVE NOT RECRUITINGN/ANCT07428252Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant MelanomaInstitute of Oncology Ljubljana
- RECRUITINGNCT04708171The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma ResectionsErasmus Medical Center · PI: Jasper Gerritsen, MD
- RECRUITINGPhase 2NCT0455921768Ga-DOTATATE Neuroblastoma Imaging PilotCentre de recherche du Centre hospitalier universitaire de Sherbrooke · PI: Etienne Rousseau, MD, FRCPC
- RECRUITINGN/ANCT04543201Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade GliomaUniversity of Rochester · PI: Sara Hardy, MD
- RECRUITINGPhase 2NCT04594187Nodal Radiation Therapy for Sentinel Lymph Node Positive MelanomaM.D. Anderson Cancer Center · PI: Devarati Mitra
- RECRUITINGNCT06782984Drug Response Testing and Repurposing Using Glioblastoma OrganoidChungnam National University Hospital · PI: Kyung Hwan Kim, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT04876456A Phase II Trial of Cabozantinib With Patients With Refractory GCTsJennifer King · PI: Jennifer King, MD
- RECRUITINGEarly Phase 1NCT04741997Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaH. Lee Moffitt Cancer Center and Research Institute · PI: Zeynep Eroglu, MD
- RECRUITINGPHASE1, PHASE2NCT04590664Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated GlioblastomaEmory University · PI: William L Read, MD
- ACTIVE NOT RECRUITINGNCT04666272Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete ResectionNovartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- ACTIVE NOT RECRUITINGN/ANCT04671693A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.Centre Leon Berard · PI: Mauricette MICHALLET, PhD, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04356729A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic MelanomaElizabeth Buchbinder, MD · PI: Elizabeth Buchbinder, MD
- ACTIVE NOT RECRUITINGN/ANCT04435756A Study of miRNA 371 in Patients With Germ Cell TumorsSWOG Cancer Research Network · PI: Craig R Nichols
- RECRUITINGPHASE1, PHASE2NCT03145857A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to UseAHS Cancer Control Alberta · PI: Todd PW McMullen, MD, PhD, FRCSC, FACS
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03958383IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for MelanomaUniversity of Wisconsin, Madison · PI: Paul Sondel, MD, PhD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03866109A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMTGenenta Science · PI: Gaetano Finocchiaro, MD
- RECRUITINGN/ANCT03941756Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaM.D. Anderson Cancer Center · PI: Mark Schaverien
- ACTIVE NOT RECRUITINGPhase 2NCT03213704Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)National Cancer Institute (NCI) · PI: Katherine A Janeway
- ACTIVE NOT RECRUITINGPhase 2NCT02743819Pembrolizumab and Ipilimumab After Prior Immunotherapy for MelanomaUniversity of Chicago · PI: Thomas Gajewski, M.D.
- ACTIVE NOT RECRUITINGPhase 3NCT02506153Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by SurgeryNational Cancer Institute (NCI) · PI: Sapna Patel
- RECRUITINGPhase 2NCT02394626Surgery for Recurrent GlioblastomaInsel Gruppe AG, University Hospital Bern · PI: Philippe Schucht, Prof. Dr. med.
- RECRUITINGPhase 3NCT02429687TC or BEP in Treating Patients With Malignant Ovarian Germ Cell TumorsBeihua Kong · PI: Beihua Kong
- RECRUITINGPhase 2NCT01876771A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine TumoursAHS Cancer Control Alberta · PI: Donald W Morrish, MD, PhD
- ACTIVE NOT RECRUITINGPhase 4NCT02068196A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.Oslo University Hospital · PI: Tormod K Guren, MD PhD
- ACTIVE NOT RECRUITINGPhase 2NCT01841736Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid TumorsNational Cancer Institute (NCI) · PI: Emily K Bergsland
- ACTIVE NOT RECRUITINGN/ANCT01358058Proton Radiation Therapy for GliomasMassachusetts General Hospital · PI: Helen A Shih, MD